It has been one year since the Narendra Modi government in India imposed a nationwide lockdown in response to the COVID-19 pandemic.
Today we take a look at recent reports of the killing of civilians in the Tigray region, custodial deaths of Indigenous people in Australia, police repression against a protest in Jordan, and the key lessons learned as India marks 1 year of the Covid-19 lockdown
Bharat Biotech has claimed in a press release that its Covid-19 vaccine candidate, Covaxin, showed 81% efficacy in the “first interim analysis” of phase-3 trials.
The recent regulatory clearance given to an indigenous developed vaccine candidate in India is an example of vaccine nationalism at its worst and jettisoning of all the principles of an evidence-based, scientific approach
The new vaccine candidate by Moderna Inc, called mRNA-1273, has reportedly shown 94.5% efficacy against the SARS-CoV-2 in the phase III clinical trials